Please login to the form below

Not currently logged in
Email:
Password:

RedHill Biopharma

This page shows the latest RedHill Biopharma news and features for those working in and with pharma, biotech and healthcare.

RedHill Biopharma’s SK2 inhibitor shows promise against coronavirus

RedHill Biopharma’s SK2 inhibitor shows promise against coronavirus

RedHill Biopharma has announced that its experimental sphingosine kinase-2 (SK2) opaganib demonstrated potent inhibition of SARS-CoV-2 in an in vitro clinical test. ... benefit COVID-19 patients by inhibiting the key drivers of disease progression -

Latest news

  • RedHill Biopharma advances phase 2/3 COVID-19 programme RedHill Biopharma advances phase 2/3 COVID-19 programme

    Submits clinical trial applications in Mexico and Brazil. Israeli biopharmaceutical company RedHill Biopharma has announced that it has accelerated its COVID-19 programme with the submission of new clinical trial applications ... Last month, RedHill

More from news
Approximately 2 fully matching, plus 0 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Fishawack Group of Companies

The Fishawack Group of Companies is one of the largest independent medical communications and medical marketing specialists, with teams in...

Latest intelligence

InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE....
Alone we can do so little, together we can do so much
Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...
7 important considerations for creating an inclusive clinical trial website
You might have noticed that all of us here at COUCH Health are big advocates for taking action to improve diversity and inclusion in the world of clinical research. ‘Taking...

Infographics